Shares of Dendreon Corp. (DNDN) have been halted and the company just announced they have received FDA Approval for Provenge.
FDA clears Dendreon's prostate cancer vaccine.
Before the stock halt, Dendreon's stock traded above $45 per share. When DNDN reopens for trading this afternoon, I expect shares to trade between $50-$60.
Today's Biggest Stock Market Gainers - Top 2010 Stock Gainers - Top 2010 Penny Stocks - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Hot OTC Stocks - Stocks for 2010
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free